Biosensors For Monitoring Research Articles

What hepatology clinicians and their patients with alcohol-related liver disease think of wearable alcohol biosensors to aid abstinence from alcohol: A qualitative study.

We aimed to determine acceptability and feasibility of innovative wearable alcohol biosensor monitors (ABM) for patients with alcohol-related liver disease (ALD) and their clinicians. Patients and clinicians at a tertiary care centre participated in qualitative interviews on usability, acceptability, feasibility, efficiency/effectiveness, impact of device on behaviour/clinical practice and preferences/barriers. Interviews were audiotaped, transcribed and coded using a constant comparison method for category themes. Patients (n = 23) were 56% female, mean 44 years old, 87% White, with moderate-severe liver disease. Some felt the ABMs appearance was unappealing; others felt it provided an opportunity for openness and education of others. While some found it feasible to wear, others felt it was unrealistic to wear 24/7. Importantly, there were many positive themes on effectiveness/efficiency-participants felt the ABM could better record their alcohol use and patterns of use than they could remember. Patients felt wearing the ABM motivated abstinence, gave accountability and was a source of security. Clinicians (n = 13) were mostly hepatologists (77%), seeing on average 38 ALD patients/month. Clinicians felt seeing patterns and amounts of alcohol use could inform clinical decision making and treatments but expressed concern over the volume and complexity of data. Perspectives on ABMs for managing ALD were mixed among patients and providers. Future device designs may overcome acceptability barriers due to device appearance. However, for clinicians, the logistics of data gathering plus the complexity and volume of data produced by the ABM device requires considerable thought to make this an efficient tool for clinical use. gov identifier NCT03533660: Alcohol biosensor monitoring for alcohol liver disease.

Biosensors for Monitoring, Detecting, and Tracking Dissemination of Poultry-Borne Bacterial Pathogens Along the Poultry Value Chain: A Review.

The poultry industry plays a crucial role in global food production, with chickens being the most widely consumed as a rich protein source. However, infectious diseases pose significant threats to poultry health, underscoring the need for rapid and accurate detection to enable timely intervention. In recent years, biosensors have emerged as essential tools to facilitate routine surveillance on poultry farms and rapid screening at slaughterhouses. These devices provide producers and veterinarians with timely information, thereby promoting proactive disease management. Biosensors have been miniaturized, and portable platforms allow for on-site testing, thereby enhancing biosecurity measures and bolstering disease surveillance networks throughout the poultry supply chain. Consequently, biosensors represent a transformative advancement in poultry disease management, offering rapid and precise detection capabilities that are vital for safeguarding poultry health and ensuring sustainable production systems. This section offers an overview of biosensors and their applications in detecting poultry diseases, with a particular emphasis on enteric pathogens.

Preparation and application of ZnO-Ecoflex composite sensors for lactate detection during physical training

This study presents the development of a flexible ZnO-Ecoflex composite sensor for noninvasive lactate detection during physical training. ZnO nanostructures with an average diameter of 50 nm were synthesized and incorporated into an Ecoflex matrix. The optimized sensor, featuring 15 wt% ZnO loading, demonstrated high sensitivity (22.7 μA·mM⁻¹·cm⁻²) and a low detection limit (2.3 μM). The composite displayed impressive mechanical characteristics, showcasing a tensile strength of 1.3 MPa and an elongation at fracture of 390%. Electrochemical characterization revealed a diffusion-controlled electron transfer process and rapid response time of 5 seconds. The sensor showed minimal interference from common sweat components (<3.2% relative response) and maintained consistent performance under various bending conditions (RSD 3.2%). Real-time monitoring during a 30-minute jogging session demonstrated the sensor's ability to capture dynamic changes in sweat lactate levels. This research contributes to the development of wearable biosensors for continuous lactate monitoring in sports and exercise science, offering potential for personalized training optimization.

LIG-Based High-Sensitivity Multiplexed Sensing System for Simultaneous Monitoring of Metabolites and Electrolytes.

With improvements in medical environments and the widespread use of smartphones, interest in wearable biosensors for continuous body monitoring is growing. We developed a wearable multiplexed bio-sensing system that non-invasively monitors body fluids and integrates with a smartphone application. The system includes sensors, readout circuits, and a microcontroller unit (MCU) for signal processing and wireless communication. Potentiometric and amperometric measurement methods were used, with calibration capabilities added to ensure accurate readings of analyte concentrations and temperature. Laser-induced graphene (LIG)-based sensors for glucose, lactate, Na+, K+, and temperature were developed for fast, cost-effective production. The LIG electrode's 3D porous structure provided an active surface area 16 times larger than its apparent area, resulting in enhanced sensor performance. The glucose and lactate sensors exhibited high sensitivity (168.15 and 872.08 μAmM-1cm-2, respectively) and low detection limits (0.191 and 0.167 μM, respectively). The Na+ and K+ sensors demonstrated sensitivities of 65.26 and 62.19 mVdec-1, respectively, in a concentration range of 0.01-100 mM. Temperature sensors showed an average rate of resistance change per °C of 0.25%/°C, within a temperature range of 20-40 °C, providing accurate body temperature monitoring.

Metamaterial biosensors for driver monitoring

Metamaterial biosensors for driver monitoring

Nanoparticle-based Biosensors for Detection of Heavy Metal Ions

Heavy metal pollution is one of the most serious environmental problems in the world. Many efforts have been made to develop biosensors for monitoring heavy metals in the environment. Development of nanoparticle-based biosensors is the most effective way to solve this problem. This review presents the latest technology of nanoparticle-based biosensors for environment monitoring to detect heavy metal ions, which are magnetic chitosan biosensor, colorimetric biosensor, and electrochemical biosensor. Magnetic chitosan biosensor acts as a nanoabsorbent, which can easily detect and extract poisonous heavy metal ions such as lead ions and copper ions. There are several methods to prepare the chitosan based on the nanoparticle, which are cross-linking, co-precipitation, multi-cyanoguanidine, and covalent binding method. In colorimetric biosensor, gold and silver nanoparticles are commonly used to detect the lead and mercury ions. In addition, this biosensor is very sensitive, fast and selective to detect metal ions based on the color change of the solution mixture. Meanwhile, electrochemical biosensor is widely used to detect heavy metal ions due to a simple and rapid process, easy, convenient and inexpensive. This biosensor is focused on the surface area, which leads to significant improvement in the performance of devices in terms of sensitivity. The wide surface area can affect the performance of the biosensor due to a limited space for operation of electrode. Therefore, reduced graphene oxide is a suitable material for making the electrochemical biosensor due to a wide surface area, good conductivity and high mechanical strength. In conclusion, these three technologies have their own advantages in making a very useful biosensor in the detection of heavy metal ions.

Enhanced bipolar electrode electrochemiluminescence biosensor for ultrasensitive monitoring of alkaline phosphatase activity during osteoblast differentiation by integrating electrocatalytic and enzymatic strategies

Alkaline phosphatase (ALP) is an important biomarker that reflects osteoblast activity and bone growth. Accurately detecting ALP activity is of pivotal clinical significance for the diagnosis and differentiation of bone system diseases. In this work, an enhanced bipolar electrode electrochemiluminescence (BPE-ECL) biosensor based on enzyme catalysis and electrocatalysis was proposed for ultrasensitive detection of ALP in osteoblasts. Carbon nitride nanosheets (CNNS) were utilized as electrocatalysts to facilitate the electrochemical reaction of bipyridine ruthenium (Ru(bpy)32+) and tripropylamine (TPrA) in the reporting cell. Meanwhile, in the sensing cell, the target ALP catalyzed the conversion of p-aminophenyl phosphate monohydrate into p-aminophenol (p-AP). The p-AP was subsequently oxidized at the anode of the driving electrode, producing electrons and increasing the Faradaic current of BPE. The dual-signal amplification strategy, combining electrocatalysis and enzyme catalysis, resulted in a 10-fold enhancement of the ECL intensity of Ru(bpy)32+/TPrA. The BPE-ECL biosensor achieved ultrasensitive detection of ALP with a detection limit as low as 1.9×10−6 U/L, and was successfully applied to monitor ALP activity in osteoblast cells. Additionally, a portable smartphone imaging was developed for the visual detection of ALP. This research introduces an innovative BPE-ECL biosensor for the monitoring of ALP activity and point-of-care testing (POCT) in osteoblasts in clinical settings.

Percutaneous Wearable Biosensors: A Brief History and Systems Perspective

AbstractWearable biosensors are envisioned to disrupt both delivery and accessibility of healthcare by providing real‐time, continuous monitoring of informative and predictive physiological markers in convenient, user‐friendly, and portable designs. In recent years, there has been myriad demonstrations of biosensor‐integrated clothing and skin‐borne biosensor patches, enabled by device miniaturization, reduced power consumption, and new biosensing chemistries. Despite these impressive demonstrations, most consumer‐grade wearables have been limited to biophotonic and biopotential sensing methods to extrapolate information such as pulse, blood oxygenation, and electrocardiograms. The only commercial example of wearable electrochemical sensing methods is for glucose monitoring. However, there is a growing interest in developing percutaneous biosensors for monitoring in interstitial fluid (ISF), which offers direct access to popular analytes such as glucose, lactate, and urea, as well as new targets like hormones, antibodies, and even medications. Herein, a brief context for the current status of wearable biosensors is provided and assess the major engineering successes and pitfalls of percutaneous biosensors over the past five years, with a view to identifying areas for further developments that will enable deployable, clinical‐ or consumer‐grade systems.

Novel FRET-Based Biosensors for Real-Time Monitoring of Estrogen Receptor Dimerization and Translocation Dynamics in Living Cells.

Estrogen receptors (ERs), comprising ER α and ER β, are crucial for regulating cell growth and differentiation via homo- and hetero-dimer formation. However, accurately detecting ER dimerization with precise spatiotemporal resolution remains a significant challenge. In this study, fluorescence resonance energy transfer-based biosensors to monitor ER dynamics in real-time, are developed and optimized.This approach involves comprehensive structural analysis, linker comparison, and the selection of optimal fluorescent protein pairs, resulting in three distinct biosensors capable of detecting all ER homo- and hetero-dimerizations within the nucleus. These biosensors are utilized to reveal interactions between ER α/β and calmodulin during dimer formation.Furthermore, by leveraging the ligand-binding domain (LBD) of ER β, ER ββ LBD biosensor is designed for real-time analysis of ER ββ homodimerization in the cytoplasm, enhancing the ability to screen ER dimerization-related drugs.Additionally, we developed a novel ER ββ translocation biosensor, which enables real-time observation of ER ββ translocation to the nucleus-a capability previously unavailable, is developed. This spatiotemporal analysis demonstrates the relevance of ER translocation in response to drug binding efficacy and extracellular matrix changes. Our biosensors offertransformative tools for studying ER dynamics, providing valuable insights for drug screening and the investigation of ER-related cellular processes.

An In2O3/In2S3 photoanode-driven whole-cell biocathode sensor for sensitive detection of nitrate

Whole-cell biocathode sensor is a new form of self-regenerable biosensor and promising for environmental monitoring especially in the scenario with low organic substrate. However, external power supply such as electrochemical workstation is required to drive the biocathode reaction, which greatly limits its application. Herein, a new strategy based on the visible-light-driven whole-cell biocathode was proposed and validated for self-powered sensitive detections. To be specific, 1-OH phenazine was selected as the optimal electron shuttle for a Shewanella oneidensis MR-1 inoculated biocathode, which efficiently mediate the cathodic reaction at an electrode potential below −0.6 V (vs. SCE). Meanwhile, an In2O3/In2S3 photoanode with nanoflower-like structure was fabricated to match the kinetic of the biocathode. The photo-driven biocathode reduction was convinced by comparing with the performance of biocathode in the conventional three-electrode system. With this basis, a self-powered whole-cell biocathode sensor was developed for nitrate detection. An extreme low limit of detection of 0.028 μM (S/N=3) and linear detection range of 0.1–20 μM was achieved. Moreover, this biocathode sensor also exhibited excellent selectivity, reusability, accuracy, stability and was reliable for the detection of complex environmental samples. Therefore, this work developed a new photo-driven whole-cell biocathode sensor with excellent detection capacity of nitrate, which opens up new prospects for the development of high-performance biosensors.

Hydrocarbonoclastic Biofilm-Based Microbial Fuel Cells: Exploiting Biofilms at Water-Oil Interface for Renewable Energy and Wastewater Remediation.

Microbial fuel cells (MFCs) represent a promising technology for sustainable energy generation, which leverages the metabolic activities of microorganisms to convert organic substrates into electrical energy. In oil spill scenarios, hydrocarbonoclastic biofilms naturally form at the water-oil interface, creating a distinct environment for microbial activity. In this work, we engineered a novel MFC that harnesses these biofilms by strategically positioning the positive electrode at this critical junction, integrating the biofilm's natural properties into the MFC design. These biofilms, composed of specialized hydrocarbon-degrading bacteria, are vital in supporting electron transfer, significantly enhancing the system's power generation. Next-generation sequencing and scanning electron microscopy were used to characterize the microbial community, revealing a significant enrichment of hydrocarbonoclastic Gammaproteobacteria within the biofilm. Notably, key genera such as Paenalcaligenes, Providencia, and Pseudomonas were identified as dominant members, each contributing to the degradation of complex hydrocarbons and supporting the electrogenic activity of the MFCs. An electrochemical analysis demonstrated that the MFC achieved a stable power output of 51.5 μW under static conditions, with an internal resistance of about 1.05 kΩ. The system showed remarkable long-term stability, which maintained consistent performance over a 5-day testing period, with an average daily energy storage of approximately 216 mJ. Additionally, the MFC effectively recovered after deep discharge cycles, sustaining power output for up to 7.5 h before requiring a recovery period. Overall, the study indicates that MFCs based on hydrocarbonoclastic biofilms provide a dual-functionality system, combining renewable energy generation with environmental remediation, particularly in wastewater treatment. Despite lower power output compared to other hydrocarbon-degrading MFCs, the results highlight the potential of this technology for autonomous sensor networks and other low-power applications, which required sustainable energy sources. Moreover, the hydrocarbonoclastic biofilm-based MFC presented here offer significant potential as a biosensor for real-time monitoring of hydrocarbons and other contaminants in water. The biofilm's electrogenic properties enable the detection of organic compound degradation, positioning this system as ideal for environmental biosensing applications.

Enhanced detection of HER2 using a TiVC MXenes/gold nanocomposite amplified analytical biosensor for precise cancer biomarker monitoring

Enhanced detection of HER2 using a TiVC MXenes/gold nanocomposite amplified analytical biosensor for precise cancer biomarker monitoring

703P Integrated Organ-on-Chip platform with PINP plasmonic biosensor for fibrosis monitoring in Duchenne muscular dystrophy

703P Integrated Organ-on-Chip platform with PINP plasmonic biosensor for fibrosis monitoring in Duchenne muscular dystrophy

Dual-functional carbon nanotube yarn supercapacitor for real-time reactive oxygen species monitoring and sustainable energy supply in implantable device

Smart stents integrate embedded sensors and advanced technology, providing a real-time diagnostic feedback, particularly for detection of thrombotic events. A continuous monitoring reactive oxygen species (ROS) in blood vessels is crucial for cardiovascular disease. The provision of a continuous power supply to sensors integrated within blood vessels is challenging. This study introduces a novel device that combines a sensor and supercapacitor, functioning as a ROS sensor and enabling continuous charging and discharging within blood vessels. This device uses yarn-shaped electrodes integrated with cytochrome c and carbon nanotubes (Cyt.c/CNT). The Cyt.c/CNT electrode exhibits a high specificity to ROS with an sensitivity (49.02 μA μM−1 cm−2), as a real-time biosensor for monitoring of cellular ROS levels in living cells. In addition, it exhibited an energy storage performance of 257.95 mF cm−2 as a supercapacitor and maintained a stable performance during 10,000 repeated cycles in various biofluids. Notably, the integration of the Cyt.c/CNT electrode with an enzymatic biofuel cell enables continuous charging and discharging in a biofluid, making it a promising system for in-vivo applications. This study presents the potential of Cyt.c for ROS sensing as well as its potential as an energy storage system, showing new possibilities for implantable devices for cardiovascular diseases.

Engineering bacterial biocatalysts for the degradation of phthalic acid esters.

Phthalic acid esters (PAEs) are synthetic diesters derived from o-phthalic acid, commonly used as plasticizers. These compounds pose significant environmental and health risks due to their ability to leach into the environment and act as endocrine disruptors, carcinogens, and mutagens. Consequently, PAEs are now considered major emerging contaminants and priority pollutants. Microbial degradation, primarily by bacteria and fungi, offers a promising method for PAEs bioremediation. This article highlights the current state of microbial PAEs degradation, focusing on the major bottlenecks and associated challenges. These include the identification of novel and more efficient PAE hydrolases to address the complexity of PAE mixtures in the environment, understanding PAEs uptake mechanisms, characterizing novel o-phthalate degradation pathways, and studying the regulatory network that controls the expression of PAE degradation genes. Future research directions include mitigating the impact of PAEs on health and ecosystems, developing biosensors for monitoring and measuring bioavailable PAEs concentrations, and valorizing these residues into other products of industrial interest, among others.

Inside out: Exploring edible biocatalytic biosensors for health monitoring

Edible biosensors can measure a wide range of physiological and biochemical parameters, including temperature, pH, gases, gastrointestinal biomarkers, enzymes, hormones, glucose, and drug levels, providing real-time data. Edible biocatalytic biosensors represent a new frontier within healthcare technology available for remote medical diagnosis. The main challenges to develop edible biosensors are: i) finding edible materials (i.e. redox mediators, conductive materials, binders and biorecognition elements such as enzymes) complying with Food and Drug Administration (FDA), European Food Safety Authority (EFSA) and European Medicines Agency (EMEA) regulations; ii) developing bioelectronics able to operate in extreme working conditions such as low pH (∼pH 1.5 gastric fluids etc.), body temperature (between 37 °C and 40 °C) and highly viscous bodily fluids that may cause surface biofouling issues. Nowadays, advanced printing techniques can revolutionize the design and manufacturing of edible biocatalytic biosensors.This review outlines recent research on biomaterials suitable for creating edible biocatalytic biosensors, focusing on their electrochemical properties such as electrical conductivity and redox potential. It also examines biomaterials as substrates for printing and discusses various printing methods, highlighting challenges and perspectives for edible biocatalytic biosensors.

Highly sensitive biosensors for real-time monitoring of histamine at acupoint PC6 in rats based on graphene-modified acupuncture needles.

Acupoints are the local initial response sites of acupuncture therapeutic effects. As a biomarker, histamine is released into the acupoint region and plays its role concurrently as acupuncture needles are inserted into acupoints. Hence, real-time monitoring of histamine at acupoints is important to elucidate the effectiveness of the acupoint-activation process in acupuncture. Therefore, we developed highly sensitive acupuncture/Au particles/graphene biosensors by electrodeposition, brushing, and annealing methods based on bare acupuncture needles. We achieved a histamine detection limit of approximately 4.352 (±3.419) × 10-12 mol L-1 and good sensitivity of approximately 6.296 (±3.873) μA μM-1, with satisfactory specificity, repeatability, and stability in vitro, rendering them more competitive and suitable for real-time monitoring in vivo without causing additional damage. Subsequently, we conducted real-time histamine monitoring at non-acupoint and acupoint PC6 in rats, respectively. Our results showed minimal changes at the non-acupoint, whereas a trend of initial increase followed by a decrease was observed at acupoint PC6. The change in histamine concentration at acupoint PC6 reflected its involvement in the acupoint-activation procedure. Moreover, its peak position at ∼18 min could provide guidance for optimizing needle retaining time for maximum therapeutic effect. This work presents the first real-time in vivo monitoring of histamine at acupoints with high sensitivity and underscores the specificity of histamine release between non-acupoint and acupoint PC6, demonstrating great potential for elucidating the acupoint-activation mechanisms in acupuncture. Additionally, this work expands the application of nanomaterials in the integration of medicine and engineering, which is an important aspect of the future development of materials science.

Terahertz meta-biosensor for subtype detection and chemotherapy monitoring of glioma cells

Rapid and precise identification of glioma subtypes can assist surgeons in quickly determining patients’ conditions and developing treatment plans. However, current methods face challenges such as high cost and limited sensitivity, thereby significantly hindering diagnostic efficiency. In this paper, we proposed a spectral sensing strategy by introducing terahertz biosensors for glioma subtype recognition and therapeutic efficacy monitoring. Our findings demonstrated that both the resonance frequency and amplitude of the transmission spectra varied as the cell increased. The two-dimensional fingerprint diagram could help us rapidly recognize cell subtypes. Additionally, we conducted a theoretical analysis of the sensing performance. We confirmed that the high Q-factor (∼27.8) results from toroidal dipole resonance and examined the impact of dielectric loss and the refractive index of the analyte on the resonance dip. Furthermore, we applied the biosensor in therapeutic drug screening and showed that as the concentration of tubastatin A increased, the resonance frequency shifted from 183.1 GHz to 76.2 GHz. This result indicates that the toroidal dipole constructed by the metasurface enables ultrasensitive light-matter interactions that amplify subtle cellular changes to the resonance spectrum. The proposed THz meta-biosensor demonstrates significant potential for rapid intraoperative recognition of glioma cell subtypes and therapeutic efficacy monitoring.

Field effect transistor biosensors for healthcare monitoring

AbstractThe burgeoning demand for healthcare monitoring has brought field effect transistor (FET) biosensors into the spotlight as a highly efficient detection technology. FET biosensors offer inherent advantages including high sensitivity, rapid response times, operational simplicity, integrability, and label‐free detection. These characteristics render them particularly well‐suited for detecting a diverse array of physiological parameters and biomarkers, thereby furnishing real‐time data crucial for personalized medicine and disease prevention. This review aims to elucidate recent advancements in FET biosensors within the realm of healthcare management encompassing several facets. Initially, this review systematically analyzes the device architecture, sensing mechanisms, and performance evaluation methods of FET biosensors to gain an in‐depth understanding of their operational principles and features. Subsequently, it focuses on the application of FET biosensors for detecting health‐related biomarkers encompassing nucleic acids, proteins, exosomes, viruses, etc. Lastly, the review presents engineered medical sensor prototypes predicated on FET biosensors, such as point‐of‐care testing devices, wearable sensors, and implantable sensors, underscoring their practical utility and potential in health management. In addition, the review addresses critical issues and prospects of using FET biosensors in healthcare monitoring, aiming to provide some references and insights for research and innovation in this field.

Textile waste-based biosensors for medical monitoring

The increasing demand for sustainable and eco-friendly solutions in the medical industry has driven the exploration of new materials and technologies. Waste-based textile biosensors hold significant promise due to their biocompatibility, low immunogenicity, and potential for disease monitoring and diagnostics. This article discusses the characteristics and utilization of three biopolymers: silk, cellulose, and chitosan. These polymers have unique structures that make them appropriate for applications as natural, lightweight, low-density polymers with advantageous chemical and easily degradable properties. The incorporation of biosensors, particularly those integrated into textiles, has become integral for non-invasive medical monitoring. Recent advances in biopolymer-based sensors are highlighted, underscoring their potential for continuous health monitoring and personalized healthcare. The inherent advantages of these sustainable materials, combined with their sensing capabilities, position biopolymer textile waste-based biosensors as a promising solution for wearable and implantable biomedical devices.